Company / Cash & Equivalents
DIVERSIFIED HEALTHCARE TRUST Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$105.4M
FY2025
5-year range
$105.4M / $658.1M
FY2021-FY2025
Trend
-27.1%
vs FY2024
Sector context
#74 of 133
Real Estate
What the data says
At $105M, DIVERSIFIED HEALTHCARE TRUST's cash & equivalents ranks #74 of 133 in the Real Estate sector. Cash & Equivalents has declined for 3 consecutive years, from $658M in FY2022 to $105M in FY2025.
Based on SEC 10-K filings.
$105M in FY2025 with a 5-year CAGR of +23.1%.
Declined from $246M to $105M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -45.7%
- 5-Year CAGR
- +23.1%
- 10-Year CAGR
- -
Sector benchmark
#74 of 133 in Real EstateTop 56% of 133This company $105.4M Sector average $334.0M
▼
-68.4% below sector average
Key checks
Key Insights
- DIVERSIFIED HEALTHCARE TRUST's cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of +23.1%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 27.1% year-over-year.
- Ranks #74 out of 133 companies in the Real Estate sector.
Company context
Key Data Points
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- Negative profit margin: -24.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $105.4M | -27.1% |
| FY2024 | $144.6M | -41.2% |
| FY2023 | $245.9M | -62.6% |
| FY2022 | $658.1M | +3.7% |
| FY2021 | $634.8M | +1599.4% |
| FY2020 | $37.4M | -32.0% |
| FY2019 | $55.0M | +0.0% |
| FY2018 | $55.0M | +76.0% |
| FY2017 | $31.2M | -1.6% |
| FY2016 | $31.7M | -15.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026